Wedbush Starts Imperva (IMPV) at Neutral; Compelling Play, But Fully Valued...Wait For Pullback
Tweet Send to a FriendGet Alerts IMPV Hot Sheet
Price: $41.87 +1.23%
Rating Summary:
9 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Rating Summary:
9 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Trade IMPV Now!
Wedbush initiates coverage on Imperva (NYSE: IMPV) with a Neutral. PT $34.00.
Analyst, Rohit Chopra, said, "We believe the LT outlook for the company is positive given its positioning as a leading player in one of the fastest growing segments of the security market, data security, which is growing at 20%+ y/y...Our enthusiasm for the secular tailwinds is tempered by a premium valuation which leaves little room for error, near-term spending, lack of near-term profitability and global macro issues, especially in Europe. We would be more constructive given a pullback in the shares, improvements in the IT spending environment and visibility into the ramp of profitability."
For an analyst ratings summary and ratings history on Imperva click here. For more ratings news on Imperva click here.
Shares of Imperva closed at $29.46 yesterday, with a 52 week range of $22.00-$42.41.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Rohit Chopra, said, "We believe the LT outlook for the company is positive given its positioning as a leading player in one of the fastest growing segments of the security market, data security, which is growing at 20%+ y/y...Our enthusiasm for the secular tailwinds is tempered by a premium valuation which leaves little room for error, near-term spending, lack of near-term profitability and global macro issues, especially in Europe. We would be more constructive given a pullback in the shares, improvements in the IT spending environment and visibility into the ramp of profitability."
For an analyst ratings summary and ratings history on Imperva click here. For more ratings news on Imperva click here.
Shares of Imperva closed at $29.46 yesterday, with a 52 week range of $22.00-$42.41.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Keryx Biopharma (KERX) Patents Strong; JPMorgan Starts at Overweight
- Wells Fargo Starts Quintiles (Q) at Outperform
- Iberia Capital Starts Synergy Resources Corporation (SYRG) at Outperform
Create E-mail Alert Related Categories
New Coverage
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
